We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MORT icon
2476
VanEck Mortgage REIT Income ETF
MORT
$376M
$51K ﹤0.01%
4,510
-7,659
-63% -$94.4K
SCS
2477
DELISTED
Steelcase
SCS
$51K ﹤0.01%
6,091
+4,119
+209% +$31.6K
SUP
2478
DELISTED
Superior Industries International
SUP
$51K ﹤0.01%
10,222
+9,166
+868% +$50.4K
SVC
2479
Service Properties Trust
SVC
$1.06B
$51K ﹤0.01%
1,026
+610
+147% +$28.2K
THRM icon
2480
Gentherm
THRM
$1.32B
$51K ﹤0.01%
846
+557
+193% +$37.3K
TRN icon
2481
Trinity Industries
TRN
$2.34B
$51K ﹤0.01%
2,109
+1,673
+384% +$44.5K
TSLX icon
2482
Sixth Street Specialty
TSLX
$1.82B
$51K ﹤0.01%
2,784
+465
+20% +$8.63K
VRCA icon
2483
Verrica Pharmaceuticals
VRCA
$83.5M
$51K ﹤0.01%
797
+161
+25% +$9.74K
OCEA
2484
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
$51K ﹤0.01%
+7,629
New +$64.5K
PSTX
2485
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$51K ﹤0.01%
16,791
+11,440
+214% +$68.6K
FTCH
2486
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$51K ﹤0.01%
10,445
+8,371
+404% +$45.4K
FXLV
2487
DELISTED
F45 Training Holdings Inc.
FXLV
$51K ﹤0.01%
43,291
+40,109
+1,260% +$95.3K
API
2488
Agora
API
$408M
$50K ﹤0.01%
13,890
-19,638
-59% -$75.1K
AUR icon
2489
Aurora
AUR
$13.4B
$50K ﹤0.01%
+35,810
New +$52.9K
AXSM icon
2490
Axsome Therapeutics
AXSM
$11.2B
$50K ﹤0.01%
815
+477
+141% +$31.3K
BVN icon
2491
Compañía de Minas Buenaventura
BVN
$8.55B
$50K ﹤0.01%
+6,044
New +$48.2K
DVA icon
2492
DaVita
DVA
$11.4B
$50K ﹤0.01%
613
-985
-62% -$78.9K
FRHC icon
2493
Freedom Holding
FRHC
$9.35B
$50K ﹤0.01%
703
-948
-57% -$64.2K
MDY icon
2494
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
$50K ﹤0.01%
109
-23,559
-100% -$11M
MFIN icon
2495
Medallion Financial
MFIN
$262M
$50K ﹤0.01%
+6,492
New +$52.2K
MOAT icon
2496
VanEck Morningstar Wide Moat ETF
MOAT
$12.5B
$50K ﹤0.01%
676
-31,424
-98% -$2.23M
PKX icon
2497
POSCO
PKX
$17.1B
$50K ﹤0.01%
+717
New +$44.2K
PROK icon
2498
ProKidney
PROK
$289M
$50K ﹤0.01%
4,456
+2,211
+98% +$23.5K
VCSH icon
2499
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
$50K ﹤0.01%
+662
New +$50.1K
WKC icon
2500
World Kinect Corp
WKC
$1.9B
$50K ﹤0.01%
1,962
+1,555
+382% +$42.3K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.